Biopharma News

Apr 03, 2018
By BioPharm International Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Mar 29, 2018
By BioPharm International Editors
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
Mar 29, 2018
By BioPharm International Editors
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
Mar 29, 2018
By BioPharm International Editors
The acquisition strengthens Celgene’s position in the global cellular immunotherapy space.
Mar 29, 2018
By BioPharm International Editors
The companies will co-develop and co-promote a CAR T cell therapy in the United States.
Mar 28, 2018
By BioPharm International Editors
Takeda is considering approaching Shire with a possible offer.
Mar 27, 2018
By BioPharm International Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 26, 2018
By BioPharm International Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By BioPharm International Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 21, 2018
By BioPharm International Editors
AbbVie and the International Myeloma Foundation will partner to study the role of a genetic mutation in outcomes of patients with multiple myeloma.
native1_300x100
lorem ipsum